Wu Hui Bin - Net Worth and Insider Trading
Wu Hui Bin Net Worth
The estimated net worth of Wu Hui Bin is at least $15 Million dollars as of 2024-06-23. Wu Hui Bin is the senior management of Henan Lingrui Pharmaceutical Co Ltd and owns about 614,500 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) stock worth over $15 Million. Details can be seen in Wu Hui Bin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wu Hui Bin has not made any transactions after 2021-07-29 and currently still holds the listed stock(s).
Transaction Summary of Wu Hui Bin
Wu Hui Bin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wu Hui Bin owns 1 companies in total, including Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) .
Click here to see the complete history of Wu Hui Bin’s form 4 insider trades.
Insider Ownership Summary of Wu Hui Bin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SHSE:600285 | Henan Lingrui Pharmaceutical Co Ltd | 2021-07-29 | senior management |
Wu Hui Bin Latest Holdings Summary
Wu Hui Bin currently owns a total of 1 stock. Wu Hui Bin owns 614,500 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) as of July 29, 2021, with a value of $15 Million.
Latest Holdings of Wu Hui Bin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SHSE:600285 | Henan Lingrui Pharmaceutical Co Ltd | 2021-07-29 | 614,500 | 24.30 | 14,932,350 |
Holding Weightings of Wu Hui Bin
Wu Hui Bin Form 4 Trading Tracker
According to the SEC Form 4 filings, Wu Hui Bin has made a total of 1 transactions in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) over the past 5 years, including 0 buys and 0 sells. The most-recent trade in Henan Lingrui Pharmaceutical Co Ltd is the sale of 400,000 shares on July 29, 2021, which brought Wu Hui Bin around $2 Million.
Insider Trading History of Wu Hui Bin
- 1
Wu Hui Bin Trading Performance
GuruFocus tracks the stock performance after each of Wu Hui Bin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Hui Bin is -15.18%. GuruFocus also compares Wu Hui Bin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Hui Bin within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wu Hui Bin's insider trading performs compared to the benchmark.
Performance of Wu Hui Bin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -18.18 | | | | | |
| Relative Return to S&P 500(%) | -13.35 | | | | | |
Wu Hui Bin Ownership Network
Wu Hui Bin Owned Company Details
What does Henan Lingrui Pharmaceutical Co Ltd do?
Who are the key executives at Henan Lingrui Pharmaceutical Co Ltd?
Wu Hui Bin is the senior management of Henan Lingrui Pharmaceutical Co Ltd. Other key executives at Henan Lingrui Pharmaceutical Co Ltd include Supervisors Li Jin , senior management Ye Qiang , and Directors & senior managers Chen Yan .
Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) Insider Trades Summary
Over the past 18 months, Wu Hui Bin made no insider transaction in Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285). Other recent insider transactions involving Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) include a net sale of 298,500 shares made by Wu Xi Zhen , and a net sale of 93,600 shares made by Li Jin .
In summary, during the past 3 months, insiders sold 186,100 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) in total and bought 0 shares, with a net sale of 186,100 shares. During the past 18 months, 392,100 shares of Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285) were sold and 0 shares were bought by its insiders, resulting in a net sale of 392,100 shares.
Henan Lingrui Pharmaceutical Co Ltd (SHSE:600285)'s detailed insider trading history can be found in Insider Trading Tracker table.
Henan Lingrui Pharmaceutical Co Ltd Insider Transactions
Wu Hui Bin Mailing Address
Above is the net worth, insider trading, and ownership report for Wu Hui Bin. Currently GuruFocus does not have mailing address information for Wu Hui Bin.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
